![IJMS | Free Full-Text | Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity IJMS | Free Full-Text | Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity](https://www.mdpi.com/ijms/ijms-23-07383/article_deploy/html/images/ijms-23-07383-g001-550.jpg)
IJMS | Free Full-Text | Low-Dose Rifabutin Increases Cytotoxicity in Antimitotic-Drug-Treated Resistant Cancer Cells by Exhibiting Strong P-gp-Inhibitory Activity
![In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex | Microbiology Spectrum In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex | Microbiology Spectrum](https://journals.asm.org/cms/10.1128/Spectrum.00045-21/asset/340c9fd6-b88b-4f8c-b2b2-cc96151a0881/assets/spectrum.00045-21.fp.png)
In Vitro Synergy Testing of Eravacycline in Combination with Clarithromycin and Rifabutin against Mycobacterium abscessus Complex | Microbiology Spectrum
![Antibiotics | Free Full-Text | Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41 Antibiotics | Free Full-Text | Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41](https://www.mdpi.com/antibiotics/antibiotics-09-00072/article_deploy/html/images/antibiotics-09-00072-g001-550.jpg)
Antibiotics | Free Full-Text | Rifabutin Suppresses Inducible Clarithromycin Resistance in Mycobacterium abscessus by Blocking Induction of whiB7 and erm41
![A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis | Nature Communications A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis | Nature Communications](https://media.springernature.com/full/springer-static/image/art%3A10.1038%2Fs41467-022-32043-3/MediaObjects/41467_2022_32043_Fig1_HTML.png)
A long-acting formulation of rifabutin is effective for prevention and treatment of Mycobacterium tuberculosis | Nature Communications
![Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases | ACS Bio & Med Chem Au Mutually Exclusive Interactions of Rifabutin with Spatially Distinct Mycobacterial Cell Envelope Membrane Layers Offer Insights into Membrane-Centric Therapy of Infectious Diseases | ACS Bio & Med Chem Au](https://pubs.acs.org/cms/10.1021/acsbiomedchemau.2c00010/asset/images/large/bg2c00010_0008.jpeg)